SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-006510
Filing Date
2024-01-23
Accepted
2024-01-23 16:18:01
Documents
11
Period of Report
2024-01-22
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 8-K revb-20240122.htm   iXBRL 8-K 48857
2 EX-3.1 revb-ex3_1.htm EX-3.1 11480
  Complete submission text file 0000950170-24-006510.txt   224036

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT revb-20240122.xsd EX-101.SCH 50901
5 EXTRACTED XBRL INSTANCE DOCUMENT revb-20240122_htm.xml XML 7139
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39603 | Film No.: 24552870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)